Skip to main content

Parkinson Disease News

News
12/20/2024
Lisa Kuhns, PhD, MD
Palliative care plays a critical role in improving the quality of life for patients with advanced Parkinson disease (PD) and their caregivers, yet it remains underutilized.
Palliative care plays a critical role in improving the quality of life for patients with advanced Parkinson disease (PD) and their caregivers, yet it remains underutilized.
Palliative care plays a critical...
12/20/2024
Annals of Long-Term Care
News
12/06/2024
Lisa Kuhns, PhD, MD
Patients with Parkinson disease (PD) and with a family history of the condition may experience slower disease progression and a lower risk of developing freezing of gait.
Patients with Parkinson disease (PD) and with a family history of the condition may experience slower disease progression and a lower risk of developing freezing of gait.
Patients with Parkinson disease...
12/06/2024
Annals of Long-Term Care
News
11/15/2024
Lisa Kuhns, PhD, MD
People with Parkinson disease (PD) and their care partners (CPs) face significant challenges affecting their health-related quality of life (HRQOL), with different PD symptoms impacting them as the disease progresses.
People with Parkinson disease (PD) and their care partners (CPs) face significant challenges affecting their health-related quality of life (HRQOL), with different PD symptoms impacting them as the disease progresses.
People with Parkinson disease...
11/15/2024
Annals of Long-Term Care
News
10/10/2024
Lisa Kuhns, PhD, MD
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease (PD) is not just a consequence of motor symptoms but may be an early indicator of the disease, associated with increased mortality and dementia risk, according to a study published in the Journal of Neurology,...
Depression in Parkinson disease...
10/10/2024
Annals of Long-Term Care
News
09/10/2024
Lisa Kuhns, PhD, MD
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has announced a $3 million investment in 33 research grants, marking a significant step forward in the battle against Parkinson disease and offering new hope for millions of patients worldwide, according to a press...
The Parkinson's Foundation has...
09/10/2024
Annals of Long-Term Care
News
08/27/2024
Jolynn Tumolo
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi) activity in patients with Parkinson’s disease (PD) was strongly modulated by circadian rhythms, according to a study published in Nature Communications.
Globus pallidus internus (GPi)...
08/27/2024
Annals of Long-Term Care
News
08/05/2024
Jolynn Tumolo
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients with Parkinson disease (PD) in a large international cohort had potentially actionable genetic variants, according to a study published in the journal Brain.
Approximately 15% of patients...
08/05/2024
Annals of Long-Term Care
News
07/23/2024
Grace Taylor, MS, MA
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and effectiveness of staged bilateral MRI-guided focused ultrasound subthalamotomy (FUS-STN) to treat Parkinson Disease (PD).
A study assessed the safety and...
07/23/2024
Annals of Long-Term Care
News
06/20/2024
Grace Taylor, MS, MA
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood test using artificial intelligence (AI) to predict Parkinson disease up to 7 years.
Researchers developed a blood...
06/20/2024
Annals of Long-Term Care
News
06/06/2024
Jolynn Tumolo
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug Administration (FDA) granted the investigational cell therapy bemdaneprocel a Regenerative Medicine Advanced Therapy (RMAT) designation for the treatment of Parkinson disease (PD), announced bemdaneprocel developer...
The US Food and Drug...
06/06/2024
Annals of Long-Term Care